KCK Medtech的动态

KCK Medtech Names Susan Stimson Managing Director Accomplished Executive with Over 25 Years of Medical Device Experience We are excited to announce today?that veteran executive,?Susan Stimson?will be joining KCK Medtech as Managing Director effective January 1, 2024. With over 25 years’ experience in healthcare, Susan is an accomplished executive in development and commercialization of new medical technologies at both start-ups and large public companies.??She most recently served as President & CEO of Zenflow, a company dedicated to less invasive treatment of enlarged prostate and remains as Executive Director on the company’s Board of Directors.? Her unique expertise includes serving as Chief Strategy Officer for Intersect ENT, building the company from its inception into a high growth public company.??There she devised and executed its product, commercial and long-term strategies to result in a portfolio of ENT products with over $100M in sales and an eventual sale to Medtronic for over $1B. “Susan is a proven leader and has a successful history of bringing disruptive medical devices to market. We look forward to leveraging her experience to accelerate growth in our portfolio companies and evaluation of new investments,” said Greg Garfield, Senior Managing Director of KCK MedTech. Ms. Stimson has previously worked with the KCK team as Executive in Residence working closely with portfolio companies on commercial strategy and has also served as?an independent Board Director for Gynesonics, a commercial stage medical device company in women’s health as well as for Avelas, a pharmaceutical-device company in the oncology sector. ---